BioXcel Therapeutics files for bankruptcy and enters material definitive agreement

BioXcel Therapeutics has filed an 8-K disclosing a bankruptcy or receivership event alongside a new material definitive agreement. The filing indicates a significant shift in the company's financial status, though specific terms of the restructuring or agreement remain to be detailed in subsequent filings.